Prof Jane Armitage - Clinical Trials Service Unit, Oxford University, UK
Prof Armitage talks to ecancer at the Aspirin Foundation 'Aspirin for the older person' meeting at the Royal Society of Medicine, London, 3rd November 2011. Prof Armitage discusses the risks of taking regular aspirin, such as gastrointestinal bleeding, versus the benefits it can bring to vascular disease and cancer. She discusses trials underway, such as aspirin vs placebo for various diseases, due to report 2017.